Physician profile
Julia D Kreger
NPI 1912311671
$1,461.83
in general payments reported to CMS, 2019-2025
18 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.82 · 2020: $147 · 2021: $225 · 2022: $67.77 · 2023: $376 · 2024: $375 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.74 |
| Education | $283.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $248.26 | 2024-2025 | |
| Allergan, INC. | $241.57 | 2020-2022 | |
| Abbvie INC. | $147.23 | 2019-2025 | |
| Lilly USA, LLC | $143.24 | 2021-2024 | Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $96.79 | 2020-2025 | |
| Pfizer INC. | $75.05 | 2023-2025 | |
| Janssen Biotech, INC. | $75.01 | 2021-2023 | Stelara, Simponi Aria, Simponi |
| Galderma Laboratories, L.P. | $66.25 | 2023-2025 | Aklief |
| Regeneron Healthcare Solutions, INC. | $65.42 | 2023-2024 | Dupixent |
| Biofrontera INC. | $61.55 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Solta Medical, A Division of Bausch Health US, LLC | $47.96 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $41.57 | 2021-2023 | Jublia |
| Leo Pharma INC. | $38.14 | 2022-2023 | Adbry |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.69 | 2023 | Spevigo |
| Incyte Corporation | $25.07 | 2024 | Opzelura |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $21.69 | 2021 | |
| Dermira, INC. | $20.94 | 2020 | |
| Organon LLC | $14.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Kreger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.